Together Pharma Statistics
Total Valuation
Together Pharma has a market cap or net worth of ILS 57.57 million. The enterprise value is 115.27 million.
Market Cap | 57.57M |
Enterprise Value | 115.27M |
Important Dates
The last earnings date was Thursday, November 28, 2024.
Earnings Date | Nov 28, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Together Pharma has 13.74 million shares outstanding. The number of shares has increased by 14.48% in one year.
Current Share Class | n/a |
Shares Outstanding | 13.74M |
Shares Change (YoY) | +14.48% |
Shares Change (QoQ) | +44.60% |
Owned by Insiders (%) | 69.15% |
Owned by Institutions (%) | n/a |
Float | 4.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.43 |
PB Ratio | 1.13 |
P/TBV Ratio | 3.96 |
P/FCF Ratio | 5.32 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.03, with an EV/FCF ratio of 10.65.
EV / Earnings | -45.06 |
EV / Sales | 1.20 |
EV / EBITDA | 4.03 |
EV / EBIT | 4.88 |
EV / FCF | 10.65 |
Financial Position
The company has a current ratio of 1.25, with a Debt / Equity ratio of 1.24.
Current Ratio | 1.25 |
Quick Ratio | 0.34 |
Debt / Equity | 1.24 |
Debt / EBITDA | 2.05 |
Debt / FCF | 5.43 |
Interest Coverage | 1.31 |
Financial Efficiency
Return on equity (ROE) is 0.23% and return on invested capital (ROIC) is 17.56%.
Return on Equity (ROE) | 0.23% |
Return on Assets (ROA) | 10.29% |
Return on Capital (ROIC) | 17.56% |
Revenue Per Employee | 661,297 |
Profits Per Employee | -17,641 |
Employee Count | 145 |
Asset Turnover | 0.67 |
Inventory Turnover | 1.03 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.77% in the last 52 weeks. The beta is 0.43, so Together Pharma's price volatility has been lower than the market average.
Beta (5Y) | 0.43 |
52-Week Price Change | -9.77% |
50-Day Moving Average | 455.94 |
200-Day Moving Average | 477.10 |
Relative Strength Index (RSI) | 32.91 |
Average Volume (20 Days) | 10,687 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Together Pharma had revenue of ILS 95.89 million and -2.56 million in losses. Loss per share was -0.26.
Revenue | 95.89M |
Gross Profit | 36.68M |
Operating Income | 23.68M |
Pretax Income | 6.77M |
Net Income | -2.56M |
EBITDA | 27.61M |
EBIT | 23.68M |
Loss Per Share | -0.26 |
Balance Sheet
The company has 7.58 million in cash and 58.75 million in debt, giving a net cash position of -51.17 million or -3.72 per share.
Cash & Cash Equivalents | 7.58M |
Total Debt | 58.75M |
Net Cash | -51.17M |
Net Cash Per Share | -3.72 |
Equity (Book Value) | 47.50M |
Book Value Per Share | 3.70 |
Working Capital | 17.66M |
Cash Flow
In the last 12 months, operating cash flow was 12.66 million and capital expenditures -1.83 million, giving a free cash flow of 10.82 million.
Operating Cash Flow | 12.66M |
Capital Expenditures | -1.83M |
Free Cash Flow | 10.82M |
FCF Per Share | 0.79 |
Margins
Gross margin is 38.25%, with operating and profit margins of 24.69% and -2.67%.
Gross Margin | 38.25% |
Operating Margin | 24.69% |
Pretax Margin | 7.06% |
Profit Margin | -2.67% |
EBITDA Margin | 28.79% |
EBIT Margin | 24.69% |
FCF Margin | 11.29% |
Dividends & Yields
Together Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.48% |
Shareholder Yield | -14.48% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on August 13, 2023. It was a reverse split with a ratio of 0.1.
Last Split Date | Aug 13, 2023 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Together Pharma has an Altman Z-Score of -0.36. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.36 |
Piotroski F-Score | n/a |